Skip to main content
Rise up! Award for Özgün Göcke

News categories: Honors & Funding

Özgün Göcke receivs Rise up! Award 2024

The Rise up! programme is aimed at outstanding and unusually creative basic researchers from the fields of biology, chemistry and medicine who have accepted a W2 professorship at a German university for the first time. The award is endowed with up to 600,000 euros each. 

The Boehringer Ingelheim Foundation recently awarded ImmunoSensation2 member Prof Özgün Gökce with the Rise up! award 2024. Göcke heads the ‘Systems Neuroscience - Cell Diversity’ working group at the Department of Neurodegenerative Diseases and Gerontopsychiatry at the UKB. The neurobiologist is looking for the key to the mechanisms of brain ageing. To this end, he plans to use new spatial transcriptomics technologies to investigate the basic principles of the nervous system in both healthy and diseased states. His project focuses on investigating how lipids alter and modulate adaptive and innate immune responses in the context of ageing and neurodegeneration.

 

Contact

Prof. Özgün Göcke

Medical Faculty, University of Bonn

& German Center for Neurodegenerative Diseases

mail: Ozgun.Goekce@ukbonn.de

 


 

 

Related news

Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

News categories: Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry
Gruppenbild Preistrager Lisec Artz Preisverleihung

News categories: Honors & Funding

Niklas Klümper and Varun Venkataramani receive Lisec-Artz Prize

Dr. Varun Venkataramani of the Faculty of Medicine at Heidelberg University and ImmunoSensation² member Dr. Niklas Klümper of the University Hospital Bonn have been awarded the Lisec Artz Prize for their outstanding cancer research. The University of Bonn Foundation and the University of Bonn Faculty of Medicine presented the awards to the two researchers on Tuesday, November 18, 2025 at the University Hospital Bonn (UKB) as part of the Cluster Science Days event held by the ImmunoSensation² Cluster of Excellence. The prize is worth a total of 15,000 euros.
View entry

Back to the news overview